Gene Editing Service market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Gene Editing Service market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Ex-Vivo
In-Vivo
Segment by Application
Commercial
Academic Research
By Company
Caribou Biosciences
CRISPR Therapeutics
Merck KGaA
Editas Medicine
Thermo Fisher Scientific
Horizon Discovery
Genscript Biotech
GeneCopoeia
Integrated DNA Technologies
Eurofins Genomics
DNA 2.0 (ATUM)
BBI Life Sciences
Genewiz
Gene Oracle
SBS Genetech
Bio Basic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
